C
CLB icon

Cerebellum’s Core Laboratories CLB Stock Holding History

Cerebellum’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$61K Buy
+3,965
New +$83.1K 0.28% 264
2019
Q3 		– Sell
-6,289
Closed -$329K – 439
2019
Q2 		$329K Buy
+6,289
New +$369K 0.27% 284

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cerebellum's CLB Position: Q3 2020 in Review

Cerebellum opened a new position in Core Laboratories (CLB) in Q3 2020: 3,965 shares worth $61K. The stake represents 0.28% of the portfolio and ranks #264 among its holdings. This is a return to the name: Cerebellum previously reported a position in CLB as recently as Q2 2019.

Cerebellum first reported a position in CLB in Q2 2019 and has held it in 2 quarters since. The position peaked at $329K in Q2 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Cerebellum held 3,965 shares of Core Laboratories worth $61K as of Q3 2020.
  • Core Laboratories was a new Cerebellum position in Q3 2020.
  • Core Laboratories made up 0.28% of Cerebellum's portfolio in Q3 2020, its #264 holding.
  • Cerebellum first reported a position in Core Laboratories in Q2 2019 and has held it in 2 quarters since.
  • Cerebellum's Core Laboratories position peaked at $329K in Q2 2019.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.